Novanta: The Selloff Still Leaves Little Room For Error
Baird Maintains Outperform on Novanta, Lowers Price Target to $175
Novanta Stock Earnings Beat Keeps Riverpoint Integration In Focus
Novanta Inc (NOVT) Q3 2026 Earnings Call Highlights: Record Margins, Strong Bookings and a ...
Novanta (NOVT) Q3 2026 Earnings Call Transcript
What Novanta (NOVT) Said on Its Q3 Earnings Call
Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026
Novanta (NOVT) to report earnings tomorrow: here is what to expect
Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript
Novanta Inc. Q3 2026 Earnings Call Summary
Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates
Novanta’s (NASDAQ:NOVT) Q3 2026 sales beat estimates but guides down full-year adjusted EPS
Novanta: Q3 Earnings Snapshot
Novanta Announces Financial Results for the Third Quarter 2026
Novanta Lowers FY2026 Adj EPS Guidance from $3.68-$3.74 to $3.66-$3.71 vs $3.69 Est; Raises FY2026 Sales Guidance from $1.130B-$1.140B to $1.135B-$1.140B vs $1.134B Est
Novanta Q3 Adj. EPS $1.05 Beats $0.97 Estimate, Sales $305.008M Beat $301.010M Estimate
Novanta Sees Q4 Adj EPS $0.91-$0.96 vs $1.02 Est; Sees Sales $306.000M-$312.000M vs $308.823M Est
Novanta (NOVT): buy, sell, or hold post Q2 earnings?
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.